Spontaneous Remission in Juvenile Myasthenia Gravis: A cohort of 13 cases and review of the literature

2022 ◽  
Author(s):  
Hugo A Arroyo ◽  
Alcy R. Torres
Keyword(s):  
Myasthenia Gravis ◽  
Spontaneous Remission ◽  
Review Of The Literature ◽  
Juvenile Myasthenia Gravis

Rituximab in Severe Seronegative Juvenile Myasthenia Gravis: Review of the Literature

2012 ◽  
Vol 47 (3) ◽  
pp. 209-212 ◽  
Author(s):  
Roshan Koul ◽  
Amna Al Futaisi ◽  
Reem Abdwani
Keyword(s):  
Myasthenia Gravis ◽  
Review Of The Literature ◽  
Juvenile Myasthenia Gravis

Juvenile Myasthenia Gravis and Amblyopia

1986 ◽  
Vol 101 (2) ◽  
pp. 214-217 ◽  
Author(s):  
Naomi Ellenhorn ◽  
Neil Lucchese ◽  
Mark Greenwald
Keyword(s):  
Myasthenia Gravis ◽  
Juvenile Myasthenia Gravis

Juvenile Myasthenia gravis

2018 ◽  
Vol 45 (04) ◽  
pp. 283-287
Author(s):  
Adela Della Marina ◽  
Ulrike Schara
Keyword(s):  
Myasthenia Gravis ◽  
Operative Therapie ◽  
Klinische Symptome ◽  
Frühe Diagnosestellung ◽  
Juvenile Myasthenia Gravis ◽  
Diagnostische Möglichkeiten

ZusammenfassungDie autoimmune kindliche und juvenile Myasthenia gravis (JMG) ist bedingt durch die Autoantikörper(Ak)-Bildung gegen die postsynaptische Membran der neuromuskulären Endplatte. Die klinischen Symptome können variabel sein, von der milden okulären Symptomatik bis zu generalisierter Schwäche und respiratorischer Insuffizienz. Die klinische Präsentation und der Verlauf der JMG, insbesondere bei präpubertären Patienten, zeigen Unterschiede im Vergleich zur adulten Form. Eine Manifestation ist schon in den ersten beiden Lebensjahren möglich, in diesem Alter kann der Antikörper-Titer auch bei generalisierten Symptomen nur minimal erhöht sein. Bei den Säuglingen und sehr kleinen Kindern ist bei negativen spezifischen Antikörpern das Vorliegen eines kongenitalen myasthenen Syndroms (CMS) eine wichtige Differenzialdiagnose. Eine frühe Diagnosestellung ist bei bestehenden therapeutischen Möglichkeiten in dieser Patientengruppe wichtig. Wir geben eine Übersicht über klinische Symptome, diagnostische Möglichkeiten sowie medikamentöse und operative Therapie bei Kindern mit JMG.

scholarly journals Thoracoscopic thymectomy for juvenile myasthenia gravis

2019 ◽  
Vol 35 (5) ◽  
pp. 603-610 ◽  
Author(s):  
Aimee G. Kim ◽  
Sydney A. Upah ◽  
John F. Brandsema ◽  
Sabrina W. Yum ◽  
Thane A. Blinman
Keyword(s):  
Myasthenia Gravis ◽  
Juvenile Myasthenia Gravis

Update on juvenile myasthenia gravis

2013 ◽  
Vol 25 (6) ◽  
pp. 694-700 ◽  
Author(s):  
Wendy K.M. Liew ◽  
Peter B. Kang
Keyword(s):  
Myasthenia Gravis ◽  
Juvenile Myasthenia Gravis

scholarly journals Clinical Characteristics of Juvenile Myasthenia Gravis in Southern China

2018 ◽  
Vol 9 ◽  
Author(s):  
Xin Huang ◽  
Yingkai Li ◽  
Huiyu Feng ◽  
Pei Chen ◽  
Weibin Liu
Keyword(s):  
Myasthenia Gravis ◽  
Clinical Characteristics ◽  
Southern China ◽  
Juvenile Myasthenia Gravis

Concurrent thyrolipomatosis and thymolipoma in a patient with myasthenia gravis: a case report and review of the literature

2021 ◽  
Vol 103 (7) ◽  
pp. e212-e215
Author(s):  
T Campion ◽  
A Maity ◽  
S Ali ◽  
P Richards ◽  
A Adams
Keyword(s):  
Case Report ◽  
Myasthenia Gravis ◽  
Clinical Importance ◽  
Imaging Features ◽  
Rare Entity ◽  
Review Of The Literature ◽  
Neck Lump

We present a case of a man with a background of myasthenia gravis who presented with a neck lump, which was diagnosed as thyrolipomatosis in continuity with a very large thymolipoma. Following removal of these lesions, the patient’s myaesthenic symptoms improved. While thymolipomas are often seen in the context of myasthenia gravis, thyrolipomatosis is a rare entity and to our knowledge the concurrent finding of both lesions with myasthenia gravis has never been reported. We highlight the important imaging features of both entities and the clinical importance of recognising them.

“Mummy, my eyelids are heavy”: A case series of juvenile myasthenia gravis

2019 ◽  
pp. 112067211986760
Author(s):  
Logeswari Krishna ◽  
Nor Fadzillah Abdul Jalil ◽  
Pooi Wah Lott ◽  
Sujaya Singh ◽  
May May Choo
Keyword(s):  
Myasthenia Gravis ◽  
Case Series ◽  
Tertiary Centre ◽  
Ocular Symptoms ◽  
Ocular Myasthenia Gravis ◽  
Life Threatening ◽  
Receptor Antibodies ◽  
Juvenile Myasthenia Gravis ◽  
Anti Acetylcholine ◽  
Second Twin

Purpose: To report three cases of juvenile myasthenia gravis aged between 18 and 24 months with ocular symptoms as their first presentation. Method: A case series. Results: We present a case series of juvenile myasthenia gravis in a tertiary centre in Malaysia. Two of the three cases consist of a pair of twins who presented with ptosis of bilateral eyes; the first twin presented 4 months later than the second twin. These two cases were positive for anti-acetylcholine receptor antibodies and had generalized myasthenia gravis, whereas the other case was negative for receptor antibodies and was purely ocular myasthenia gravis. Conclusion: Juvenile myasthenia gravis is relatively rare in toddlers. Early diagnosis and commencement of treatment is important to slow the progression of the disease and avoiding life-threatening events.

Sign in / Sign up

Export Citation Format

Share Document